SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose‐derived mesenchymal stem cells via metabolic switching

Tiantong Ou,Wenlong Yang,Wenjia Li,Yijing Lu,Zheng Dong,Hongming Zhu,Xiaolei Sun,Zhen Dong,Xinyu Weng,Suchi Chang,Hua Li,Yufan Li,Zhiwei Qiu,Kai Hu,Aijun Sun,Junbo Ge
DOI: https://doi.org/10.1002/ctm2.172
IF: 8.554
2020-09-01
Clinical and Translational Medicine
Abstract:BACKGROUND: Mesenchymal stem cells (MSCs) have therapeutic potential for multiple ischemic diseases. However, in vitro expansion of MSCs before clinical application leads to metabolic reprogramming from glycolysis to oxidative phosphorylation, drastically impairing their proliferative and therapeutic capacities. This study aimed to define the regulatory effects of Sirtuin 5 (SIRT5) on the proliferative and therapeutic functions of adipose-derived MSCs (ADMSCs) during in vitro expansion.METHODS: ADMSCs were isolated from wild-type (WT) and Sirt5-knockout (Sirt5<sup>-/-</sup> ) mice. Cell counting assay was used to investigate the proliferative capacities of the ADMSCs. Dihydroethidium and senescence-associated β-galactosidase stainings were used to measure intracellular ROS and senescence levels. Mass spectrometry was used to analyze protein succinylation. Oxygen consumption rates and extra cellular acidification rates were measured as indicators of mitochondrial respiration and glycolysis. Metabolic-related genes expression were verified by quantitative PCR and western blot. Hind limb ischemia mouse model was used to evaluate the therapeutic potentials of WT and Sirt5<sup>-/-</sup> ADSMCs.RESULTS: SIRT5 protein levels were upregulated in ADMCs during in vitro expansion. Sirt5<sup>-/-</sup> ADMSCs exhibited a higher proliferation rate, delayed senescence, and reduced ROS accumulation. Furthermore, elevated protein succinylation levels were observed in Sirt5<sup>-/-</sup> ADMSCs, leading to the reduced activity of tricarboxylic acid cycle-related enzymes and attenuated mitochondrial respiration. Glucose uptake, glycolysis, and pentose phosphate pathway were elevated in Sirt5<sup>-/-</sup> ADMSCs. Inhibition of succinylation by glycine or re-expression of Sirt5 reversed the metabolic alterations in Sirt5<sup>-/-</sup> ADMSCs, thus abolishing their enhanced proliferative capacities. In the hind limb ischemia mouse model, SIRT5<sup>-/-</sup> ADMSCs transplantation enhanced blood flow recovery and angiogenesis compared with WT ADMSCs.CONCLUSIONS: Our results indicate that SIRT5 deficiency during ADMSC culture expansion leads to reversed metabolic pattern, enhanced proliferative capacities, and improved therapeutic outcomes. These data suggest SIRT5 as a potential target to enhance the functional properties of MSCs for clinical application.
oncology,medicine, research & experimental
What problem does this paper attempt to address?
The problem this paper attempts to address is the decline in proliferation capacity and therapeutic function of Mesenchymal Stem Cells (MSCs) due to metabolic reprogramming during in vitro culture. Specifically, the study focuses on the regulatory role of Sirtuin 5 (SIRT5) in the in vitro expansion of Adipose-Derived Mesenchymal Stem Cells (ADMSCs). ### Background - **Problem Background**: Mesenchymal Stem Cells (MSCs) have the potential to treat various ischemic diseases (such as myocardial infarction, limb ischemia, etc.). However, during the in vitro expansion process before clinical application, MSCs undergo metabolic reprogramming from glycolysis to oxidative phosphorylation, which significantly weakens their proliferation capacity and therapeutic efficacy. - **Research Objective**: This paper aims to explore the regulatory role of Sirtuin 5 (SIRT5) on the proliferation capacity and therapeutic function of Adipose-Derived Mesenchymal Stem Cells (ADMSCs) during in vitro expansion. ### Main Findings - **Upregulation of SIRT5 Expression**: During the in vitro expansion of ADMSCs, the protein level of SIRT5 is significantly upregulated. - **Effects of SIRT5 Knockout**: - **Enhanced Proliferation Capacity**: SIRT5 knockout ADMSCs exhibit a higher proliferation rate and delayed senescence. - **Reduced ROS Accumulation**: SIRT5 knockout ADMSCs show less accumulation of reactive oxygen species (ROS) under basal conditions and after H2O2 treatment. - **Metabolic Changes**: In SIRT5 knockout ADMSCs, the succinylation levels of enzymes related to the tricarboxylic acid cycle (TCA cycle) increase, leading to weakened mitochondrial respiration and enhanced glycolysis and pentose phosphate pathway (PPP). - **Improved Therapeutic Efficacy**: In a mouse hindlimb ischemia model, transplantation of SIRT5 knockout ADMSCs significantly enhances blood flow recovery and angiogenesis. ### Conclusion - **Main Conclusion**: The lack of SIRT5 during the in vitro expansion of ADMSCs leads to a reversal of the metabolic pattern, enhancing proliferation capacity and therapeutic efficacy. These data suggest that SIRT5 could be a potential target to improve the clinical application function of MSCs. ### Significance - **Clinical Application Prospects**: By regulating SIRT5, the function of in vitro expanded ADMSCs can be improved, thereby enhancing their efficacy in the treatment of ischemic diseases. This paper provides new insights into the role of SIRT5 in the metabolic regulation of MSCs and offers a theoretical basis for enhancing the clinical application potential of MSCs.